<?xml version="1.0" encoding="UTF-8"?>
<p>Thalidomide, a derivative of glutamic acid, is approved for erythema nodosum leprosum and is also used in many conditions such as prurigo nodularis, pyoderma gangrenosum, Bechetâ€™s disease, lupus erythematosus and erythema multiforme. It exerts anti-inflammatory effect through cereblon E3 ubiquitin ligase as the primary target and thus inhibits chemotaxis of leukocytes, monocytes as well as the production of tumor necrosis factor (TNF)-alpha, IL-8, and IL-12.</p>
